Raleigh, N.C., USA - April 15, 2016, Raleigh, N.C., USA - NephroGenex announced that it terminated Pierre Legault’s employment as the chief executive officer and president.
Article continues below
]
Mr. Legault joined NephroGenex in October 2013 as Chief Executive Officer and has been a member of the Company’s Board of Directors since November 2012. He formerly served as CEO of Prosidion Ltd., a mid-size U.K. biotechnology firm.
Mr. Legault has also served as Executive VP, Chief Financial Officer and Treasurer of OSI Pharmaceuticals, Senior Executive VP and Chief Administrative Officer of Rite Aid Corporation, and President of the Eckerd Group, with overall managerial responsibilities for the Brooks Eckerd operations in the U.S. He also held several senior positions with Sanofi-Aventis and predecessor companies.
Mr. Legault has served on the boards of Forest Laboratories, Inc. and Cyclacel Pharmaceutical Inc. He studied at McGill University, University of Montreal (HEC) and the Harvard Business School, and holds a Six Sigma Green Belt, a BAA, MBA, CA and CPA diploma.
The Company added the responsibilities of Chief Executive Officer to the Company’s Chief Financial Officer, John P. Hamill, to serve as the Company’s Chief Executive Officer and Chief Financial Officer.
Mr. Hamill has served as the Company’s Chief Financial Officer since January 2014. From June 2013 until January 2014, he served as Co-President and Chief Financial Officer of Savient Pharmaceuticals and as Senior Vice President and Chief Financial Officer of Savient since September 2012.
From 2010 to 2012, Mr. Hamill served as a financial consultant for various private companies. From 2001 until 2009, he worked for PharmaNet Development Group, Inc., where he served as Executive Vice President and Chief Financial Officer from 2006 until 2009.
During the period in which Mr. Hamill served as Executive Vice President and Chief Financial Officer, he also maintained responsibilities as the Chief Financial Officer of PharmaNet Development Group, Inc.'s wholly-owned subsidiary, PharmaNet, Inc.
Mr. Hamill earned his B.S. with a dual major in Accounting/Business and Computer Science from DeSales University (formerly Allentown College of St. Francis de Sales) in 1986. ■